Skip to main content
. Author manuscript; available in PMC: 2012 May 15.
Published in final edited form as: Clin Cancer Res. 2011 Apr 15;17(10):3170–3180. doi: 10.1158/1078-0432.CCR-10-3289

Fig. 6.

Fig. 6

Activity of hepatic PPARα and PPARγ in presence of extra-hepatic EHS tumors. Basal and induced target gene expression for PPARα (A) and PPARγ (B). Induced gene expression in non-tumor controls and tumor-bearing mice as achieved by treatment with Wy-14643 (+Wy) for PPARα activation and troglitazone (+Trog) for PPARγ activation (n = 6–9 per group). * p < 0.05 denotes a significant change in gene expression in control versus tumor groups following ligand activation.